Clinical trial
Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate…
NCT00450749 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00450749 |
|---|---|
| Title | Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer |
| Official title | Phase II Placebo Controlled Trial of Preoperative Lycopene Supplementation in Prostate Cancer Patients |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer |
| Intervention type | Drug, Other, Procedure |
| Interventions | placebo, therapeutic conventional surgery, laboratory biomarker analysis, lycopene |
| Enrollment | 10 |
| Start date | Feb 1, 2008 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Mar 22, 2007 |
| Last update posted | Dec 18, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: